Literature DB >> 3225772

Mechanism of transcorneal permeation of pilocarpine.

A K Mitra1, T J Mikkelson.   

Abstract

The mechanism of transcorneal permeation of pilocarpine has been investigated in relation to the physicochemical properties of the permeating species and its interaction with the membrane biophase. In vitro corneal transport experiments suggested the transport of un-ionized as well as ionized pilocarpine species across the corneal membrane. However, the permeability of the ionized pilocarpine species was 4.818 x 10(-6) cm s-1, a value only one-half of that obtained for the un-ionized pilocarpine species (9.744 x 10(-6) cm s-1). Further evidence of ion transport across the cornea was obtained by examining the transport of the quaternized pilocarpine compound (i.e., pilocarpinium methyl iodide). The quaternized compound had a corneal permeability of 4.66 x 10(-6) cm s-1, similar to that obtained for the ionized pilocarpine species. The lipoidal epithelial layer of the corneal membrane appears to be the predominant barrier to the transport of polar species. Therefore, the transport of pilocarpinium cations across the lipoidal epithelium might have occurred as tightly bound ion pairs with dihydrogen phosphate and/or nitrate counter ions. Excellent linear correlation has been obtained between pilocarpine corneal permeability and the 1-octanol-water partition coefficient as a function of the state of ionization of pilocarpine. The ratio of un-ionized to ionized drug permeability across the cornea is expected to be much higher for drugs with higher 1-octanol-water partition coefficients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3225772     DOI: 10.1002/jps.2600770911

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

1.  General Pharmacokinetic Model for Topically Administered Ocular Drug Dosage Forms.

Authors:  Feng Deng; Veli-Pekka Ranta; Heidi Kidron; Arto Urtti
Journal:  Pharm Res       Date:  2016-07-18       Impact factor: 4.200

2.  Evaluation of mucoadhesive polymers in ocular drug delivery. I. Viscous solutions.

Authors:  N M Davies; S J Farr; J Hadgraft; I W Kellaway
Journal:  Pharm Res       Date:  1991-08       Impact factor: 4.200

3.  Assessment of tear concentrations on therapeutic drug monitoring. II. Pharmacokinetic analysis of valproic acid in guinea pig serum, cerebrospinal fluid, and tears.

Authors:  S Sato; S Kitagawa; M Nakajima; K Shimada; A Honda; H Miyazaki
Journal:  Pharm Res       Date:  2001-04       Impact factor: 4.200

Review 4.  Ophthalmic drug design based on the metabolic activity of the eye: soft drugs and chemical delivery systems.

Authors:  Nicholas Bodor; Peter Buchwald
Journal:  AAPS J       Date:  2005-12-07       Impact factor: 4.009

5.  Prodrugs of 5-iodo-2'-deoxyuridine for enhanced ocular transport.

Authors:  M M Narurkar; A K Mitra
Journal:  Pharm Res       Date:  1989-10       Impact factor: 4.200

6.  Development of novel in silico model to predict corneal permeability for congeneric drugs: a QSPR approach.

Authors:  Charu Sharma; Thirumurthy Velpandian; Nihar Ranjan Biswas; Niranjan Nayak; Rasik Bihari Vajpayee; Supriyo Ghose
Journal:  J Biomed Biotechnol       Date:  2011-02-20

7.  Effect of formulation factors on in vitro transcorneal permeation of voriconazole from aqueous drops.

Authors:  Biswaranjan Mohanty; Sagar Kumar Mishra; Dipak K Majumdar
Journal:  J Adv Pharm Technol Res       Date:  2013-10

8.  In Vitro and In-Eye Comparison of Commercial Pilocarpine Ophthalmic Solution and an Optimized, Reformulated Pilocarpine for Presbyopia Treatment.

Authors:  Mitchell A Jackson; Jaya Giyanani; Yumna Shabaik; Jeff Penzner; Anuradha V Gore; Michael R Robinson; George O Waring
Journal:  Ophthalmol Ther       Date:  2022-03-02

9.  Comprehensive evaluation of formulation factors for ocular penetration of fluoroquinolones in rabbits using cassette dosing technique.

Authors:  Charu Sharma; Nihar R Biswas; Shreesh Ojha; Thirumurthy Velpandian
Journal:  Drug Des Devel Ther       Date:  2016-02-22       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.